ATLASPolaryx Therapeutics (PLYX) earnings date: Nov 12, 2026
Polaryx Therapeutics (PLYX) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026. Analysts expect EPS of -$0.06.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on PLYX
| Last price | $1.77 (+1.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.4% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 3 reports |
These figures come from the same calibrated model and valuation as the Polaryx Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Polaryx Therapeutics reports on Nov 12, 2026. One email the day before, with ATLAS’s read on Polaryx Therapeutics. You can switch it off at any time.
Alert me before PLYX reportsFree to start. Creating an account takes under a minute.
Notify me when Polaryx Therapeutics reports
Track PLYX free Add Polaryx Therapeutics to a free ATLAS watchlist and see its next report date in one place.
PLYX earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.06 |
| Last report | Aug 13, 2026 · Beat |
| Beat rate (last 3 reports) | 2 of 3 (67%) |
| Average EPS surprise | -34.8% |
| Average move around a report | ±12.0% (last 3) |
| Sector | Healthcare · Biotechnology |
Polaryx Therapeutics earnings history: last 3 reports
Polaryx Therapeutics last reported on Aug 13, 2026: EPS of -$0.03 against an estimate of -$0.04 (+25.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$0.04 | -$0.03 | +25.0% | Beat | +16.6% |
| Jun 23, 2026 | $0.34 | $0.41 | +20.6% | Beat | -0.4% |
| May 15, 2026 | -$0.02 | -$0.05 | -150.0% | Miss | -19.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for PLYX
See the fair value, the probability range and the earnings history of Polaryx Therapeutics on its ATLAS page.
Polaryx Therapeutics (PLYX) stock analysisPlans from €3.99 a month.
Polaryx Therapeutics earnings: frequently asked questions
When does Polaryx Therapeutics (PLYX) report earnings?
Polaryx Therapeutics is scheduled to report on Thursday, November 12, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for PLYX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.06 per share (USD). Estimates can change before the report.
How often does PLYX beat earnings estimates?
Of its last 3 reports with a recorded result, Polaryx Therapeutics beat the EPS estimate 2 times; the average surprise was -34.8%. Past results do not predict the next one.
How much does PLYX move around earnings?
Over its last 3 reports the stock moved an average of 12.0% (absolute, from the close before the report day to the close after it), and finished higher 1 of 3 times.
Did Polaryx Therapeutics beat earnings estimates last quarter?
Polaryx Therapeutics last reported on Aug 13, 2026: EPS of -$0.03 against an estimate of -$0.04 (+25.0% surprise), a beat.
How much does PLYX usually move in a day?
On a normal trading day the ATLAS model puts PLYX’s one-day range at about ±3.4%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer